Lightnews — Scholar-powered news

Molecular Oncology @moloncology.bsky.social · 3d

Patient-specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

➡️ buff.ly/OpVpLqS

#Pharmacogenomics

Molecular Oncology @moloncology.bsky.social · 6d

📄 Did you know we publish EACR Viewpoints?

📣 Introduced in 2023 when Molecular Oncology became the affiliate journal of the
EACR, EACR Viewpoints showcase authoritative opinions on cutting-edge topics in #CancerResearch.

🔓 You may access them here
➡️ bit.ly/4cIqPCh

@FEBSnews #CancerBiology

Molecular Oncology @moloncology.bsky.social · 7d

📣 New month, new Commentary

Not just a by-product: circular DNA molecules derived from V(D)J recombination are linked to worse prognosis in B-cell leukemia

🔓 buff.ly/hO4fJ9g

🖊️ @andreaventura.bsky.social

#eccDNA #ecDNA

1

Molecular Oncology @moloncology.bsky.social · 8d

The ACCEPTance of automation: refining circulating tumor cells enumeration for improved metastatic colorectal cancer prognosis

➡️ buff.ly/XfueJAy

#CTCs #mCRC #Prognosis #Oncology #CRCSM

Molecular Oncology @moloncology.bsky.social · 9d

📖 Have you leafed through our September Issue?

This Issue contains recent findings on how TME changes can alter cell function and treatment outcomes. It also highlights new therapeutic opportunities based on the TME’s dynamic landscape

🔓 buff.ly/jYUuWIM

#TumourMicroenvironment

Molecular Oncology @moloncology.bsky.social · 10d

Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia

➡️ buff.ly/yxF616I

🖊️ @HeckmanLab

#AML #MCL1 #HemOnc

Molecular Oncology @moloncology.bsky.social · 13d

🤩 We are excited to be attending 🧠EACR Cancer Neuroscience🧠 next month

👥 Are you going?

👉 buff.ly/lTaWPhW

#CancerResearch #BrainTumours
#CNScancer #NeuroOncology

2

Molecular Oncology @moloncology.bsky.social · 14d

📣The joint publishing fellowship with the EACR @helloeacr offers a remote placement at the journal

Get hands-on experience in scientific editing and visit the Heidelberg office

⏰Deadline Nov 7
➡️https://buff.ly/3ZtvMe3

#PhDchat #PostDocChat #ECRchat
#CancerResearch #CancerBiology

Molecular Oncology @moloncology.bsky.social · 15d

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

🔦 buff.ly/SkrGsPb

#Glioma #Metabolism

Molecular Oncology @moloncology.bsky.social · 16d

📣 Don't miss our new Commentary

Only the strong survive: therapeutic selective pressure drives medulloblastoma leptomeningeal metastasis

🖊️ @MSKCancerCenter @adrienne_boire

#Leptomeningeal #Metastasis #Medulloblastoma

Molecular Oncology @moloncology.bsky.social · 24d

📢Call for papers

📭Submit your latest research in the field of #LiquidBiopsy

➡️Format: Research Article, Short Report or Method
➡️Details buff.ly/ATND9t1

#ACTC2025 #CTC #ctDNA #Cancer

Molecular Oncology @moloncology.bsky.social · 27d

Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy

➡️ buff.ly/8wmhhmv

🖊️ @GroupKyte

#Microbiome #GutMicrobiota #BCSM #Immunotherapy

1 2 2

Molecular Oncology @moloncology.bsky.social · 27d

💻If you believe that curated data = quality controlled data then check out
@datadryad

🤝Thanks to our partnership, authors can now enable the open sharing & reuse of their research data

👉https://buff.ly/3BkrNqd

#OpenSource #OpenAccess #OpenResearch #OpenData #OpenScience

1 2

Molecular Oncology @moloncology.bsky.social · 29d

📄 Did you know we publish EACR Viewpoints?

📣 Introduced in 2023 when Molecular Oncology became the affiliate journal of the
@EACRnews, EACR Viewpoints showcase authoritative opinions on cutting-edge topics in #CancerResearch

🔓 You may access them here
➡️ bit.ly/4cIqPCh

@FEBSnews #CancerBiology

Molecular Oncology @moloncology.bsky.social · Sep 9

Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics

🔦 buff.ly/dsaLPGJ

#Fragmentomics #ctDNA #DNAmet #DNAmethylation

Molecular Oncology @moloncology.bsky.social · Sep 8

The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI-treated non-small cell lung cancer patients

👉 buff.ly/X1aoIai

#ROS1 #NSCLC #Oncofusions

Molecular Oncology @moloncology.bsky.social · Sep 5

⚠️Did you know?

📣Molecular Oncology is an affiliate journal with Review Commons, meaning #ReviewedPreprints can be transferred directly to the journal for editorial consideration without restarting #PeerReview

Molecular Oncology @moloncology.bsky.social · Sep 4

⌛ Did you book your spot yet?

🧠EACR Cancer Neuroscience🧠

👇Register by Sept 15

buff.ly/lTaWPhW

#CancerResearch #BrainTumours
#CNScancer #NeuroOncology

Molecular Oncology @moloncology.bsky.social · Sep 2

🔍 We are looking for papers!

🤝 In conjunction with the @EACRnews conference on #ImmunoOncology we have an active call for papers!

📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc

👉 Find out more details buff.ly/ZDb3rO0

Molecular Oncology @moloncology.bsky.social · Sep 1

Adenosine-to-inosine editing of miR-200b-3p is associated with the progression of high-grade serous ovarian cancer

👉 buff.ly/FMrZvtO

#HGSOC #miR200 #RNAediting

Molecular Oncology @moloncology.bsky.social · Aug 29

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

🔦 buff.ly/1ZZBtJh

🖊️ @DrLitvinov

#Merkelcellcarcinoma

Molecular Oncology @moloncology.bsky.social · Aug 28

Bridging the gap: Multi-stakeholder perspectives of molecular diagnostics in oncology

👉 buff.ly/ERfd897

🖊️ @TimonV

#MolOncology #Oncology #MolecularDiagnostics

Molecular Oncology @moloncology.bsky.social · Aug 27

YAP1::TFE3 mediates endothelial-to-mesenchymal plasticity in epithelioid hemangioendothelioma

👉 buff.ly/r55RHc7

Molecular Oncology @moloncology.bsky.social · Aug 26

📣 There is still time to surf through our August Issue

💡 Find a new EACR Viewpoint on integrating temporal dynamics into cancer research by Guillaume Jacquemet @guijacquemet.bsky.social

🏄‍♀️ buff.ly/pUt8m16

1 1

Molecular Oncology @moloncology.bsky.social · Aug 26

📣 Have you seen our latest Commentary?

SensRORing cholesterol to drive protumoral myelopoiesis

👉 buff.ly/tzuHla3

#Metabolism #Cholesterol #Myelopoiesis